financetom
Business
financetom
/
Business
/
Why Is Toy Maker Funko's Stock Gaining Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Is Toy Maker Funko's Stock Gaining Today?
May 10, 2024 5:47 AM

Funko Inc ( FNKO ) shares are trading higher after the company reported better-than-expected first-quarter adjusted EPS.

The company reported a first-quarter FY24 sales decline of 14.4% year-on-year to $215.699 million, missing the analyst consensus estimate of $220.267 million.

Sales in the U.S. fell 17.4% to $146.4 million, and Europe dropped 7.2% to $54.2 million.

Adjusted gross margin for the quarter expanded from 31.6% to 40%. The operating loss for the quarter narrowed to $(14.9) million from a loss of $(64.4) million last year.

Adjusted EBITDA for the quarter was $9.6 million compared to an adjusted EBITDA loss of $(14) million last year.

Adjusted EPS of $(0.17) beat the consensus of $(0.30).

Total debt was $246.4 million at March-end versus $273.6 million at December-end. The company held $26.1 million in cash and equivalents as of March-end.

“As a result of better inventory management, we achieved higher than anticipated margins on sales into the value channel, which along with better-than-expected freight costs contributed to our Q1 gross margin of 40%,” said interim CEO Michael Lunsford.

Funko’s board of directors appointed Cynthia Williams as Chief Executive Officer (CEO), effective May 20, 2024.

Outlook: Funko ( FNKO ) reiterated its FY24 sales forecast of $1.047 billion – $1.103 billion against an estimate of $1.077 billion and Adjusted EBITDA of $65 million – $85 million.

Funko ( FNKO ) sees second-quarter FY24 adjusted EPS of $(0.15) – $(0.08) versus an estimate of $(0.21).

The company expects second-quarter net sales of $225 million – $240 million versus an estimate of $230.147 million. The company sees second-quarter adjusted net loss per share of $(0.15) to $(0.08) against the consensus of $(0.21).

Price Action: FNKO shares are trading higher by 4.99% at $7.16 in premarket at the last check Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Getty Images, Shutterstock to Merge in $3.7 Billion Cash-Stock Deal
Getty Images, Shutterstock to Merge in $3.7 Billion Cash-Stock Deal
Jan 7, 2025
10:36 AM EST, 01/07/2025 (MT Newswires) -- Getty Images ( GETY ) and Shutterstock ( SSTK ) said Tuesday they agreed to combine in a merger of equals to create a visual content company with an enterprise value of about $3.7 billion. For each share owned in Shutterstock ( SSTK ), investors can choose to receive either about $28.85 in...
Actuate Therapeutics Gets Orphan Medicinal Product Label for Elraglusib in EU
Actuate Therapeutics Gets Orphan Medicinal Product Label for Elraglusib in EU
Jan 7, 2025
10:34 AM EST, 01/07/2025 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Tuesday that the European Medicines Agency has granted orphan medicinal product designation to elraglusib for the treatment of pancreatic ductal adenocarcinoma. The company said the designation is granted to therapies intended for the treatment of life-threatening diseases that affect no more than two in 10,000 people in...
Rezolute Says it Gets Breakthrough Therapy Designation From US FDA for Ersodetug to Treat Hypoglycemia
Rezolute Says it Gets Breakthrough Therapy Designation From US FDA for Ersodetug to Treat Hypoglycemia
Jan 7, 2025
10:34 AM EST, 01/07/2025 (MT Newswires) -- Rezolute ( RZLT ) said Tuesday it has received the US Food and Drug Administration's Breakthrough Therapy designation for its ersodetug monoclonal antibody to treat hypoglycemia due to congenital hyperinsulinism. The regulator's decision was based on the company's phase 2b trial of ersodetug in patients with congenital hyperinsulinism, which safely showed significant improvements...
Update: JPMorgan to Leave Net-Zero Banking Alliance
Update: JPMorgan to Leave Net-Zero Banking Alliance
Jan 7, 2025
10:35 AM EST, 01/07/2025 (MT Newswires) -- (Updates throughout with JPMorgan's ( JPM ) comments.) JPMorgan ( JPM ) is leaving climate group Net-Zero Banking Alliance, a company spokesperson told MT Newswires Tuesday. We will continue to work independently to advance the interests of our firm, our shareholders and our clients and remain focused on pragmatic solutions to help further...
Copyright 2023-2026 - www.financetom.com All Rights Reserved